Physician profile
Jenny Chen
NPI 1952684870
$4,742.86
in general payments reported to CMS, 2019-2025
20 companies · $2,128 in 2025
The $2,128 reported for 2025 was more than what 94% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $451 · 2023: $864 · 2024: $1,012 · 2025: $2,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,003.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $832.57 | 2021-2025 | Breztri, Airsupra, Fasenra |
| Medtronic, INC. | $586.08 | 2024-2025 | Percept PC Brainsense, Minimed 780g, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $464.47 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $459.53 | 2023-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.86 | 2022-2023 | Jardiance |
| Glaxosmithkline, LLC. | $357.42 | 2024-2025 | Arexvy, Shingrix |
| Abbvie INC. | $350.05 | 2023-2025 | |
| Abbott Laboratories | $145.35 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Neurocrine Biosciences, INC. | $129.77 | 2025 | |
| Angiodynamics, INC. | $128.88 | 2023 | Auryon Laser System 100-120 Vac |
| Amgen INC. | $125.00 | 2022 | |
| Alkermes, INC. | $124.98 | 2025 | Lybalvi |
| Otsuka America Pharmaceutical, INC. | $124.98 | 2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $121.05 | 2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $119.94 | 2025 | Caplyta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $118.90 | 2023 | Optimizer |
| Axsome Therapeutics, INC. | $116.50 | 2024 | Auvelity |
| Janssen Biotech, INC. | $28.70 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $21.40 | 2025 | Entyvio |
| Novo Nordisk INC | $17.43 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.